-
-
-
-
- Propylthiouracil
- Anti Thyroid
-
-
-
- Diphenhydramine
- H1 antagonist
- 1st gen
-
- Doxylamine
- H1 Antagonist
- 1st gen
-
- Carbinoxamine
- H1 Antagonist
- 1st gen
-
- Clemastine
- H1 Antagonist
- 1st gen
-
- Pyrilamine
- H1 antagonist
- 1st Gen
-
- Chlorpheniramine
- H1 antagonist
- 1st Gen
-
- Brompheniramine
- H1 antagonists
- 1st gen
-
- Triprolidine
- H1 antagonist
- 1st gen
-
- Cyclizine
- H1 antagonist
- 1st gen
-
- Meclizine
- H1 Antagonist
- 1st gen
-
- Hydroxyzine
- H1 antagonist
- 1st gen
-
- Clemizole
- H1 antagonist
- 1st gen
-
- Trimeprazine
- H1 antagonist
- 1st gen
-
-
- Azatidine
- H1 Antagonist
- 1st gen
-
- Cetrizine
- H1 blocker
- 2nd gen
-
- Fexofenadine
- H1 antagonist
- 2nd Gen
-
- Loratidine
- H1 antagonist
- 2nd Gen
-
- Acrivastine
- H1 Antagonist
- 2nd gen
-
- Astemizole
- H1 Blocker
- 2nd Gen
-
-
-
-
-
-
-
-
-
- Misoprostol
- PGE2 analog
- Cytoprotective agent
-
- Carafate
- Cytoprotective agent
-
-
-
-
-
-
- Mechlorethamine
- Nitrogen Mustard
- Alkylating agent
- Anticancer
-
- Melphalan
- Nitrogen Mustard
- Alkylating agent
- Anticancer
-
- Chlorambucil
- Nitrogen Mustard
- Alkylating Agent
- Anticancer
-
- Cyclophosphamide
- Alkylating agent
- Nitrogen Mustard
- Anticancer
-
- Carmustine
- Nitrosurea
- Alkylating agent
- Anticancer
-
- Streptozocin
- Nitrosurea
- Alkylating agent
- Anti cancer
-
- Busulfan
- Alkylating agent
- Anticancer
-
- Cisplatin
- Alkylating agent
- Anti cancer
-
- Carboplatin
- Platinum
- Alkylating agent
- Anti cancer
-
- Methotrexate
- Folic acid analog
- DHFR inhibitor
- Thymidylate synthase inhibitor
-
- 5 Fluorouracil
- thymadylate synthase inhibitor
- Anti Cancer
-
- Capecitabine
- Thymidylate Synthase inhibitor
- 5 Flurouracil prodrug
-
- Ara-C/ Cytarabine
- Differentiation agent
- Anticancer
-
- Gemcitabine
- Chain terminating agent
- Anti Cancer
-
- 6-Mercaptopurine
- Inhibition of purine synthasis
- Anticancer
-
- 6 - Thioguanine
- Inhibition of purine synthasis
- Anticancer
-
- Azatioprine
- Antimetabolite
- Anticancer
-
- Hydroxyurea
- Ribonucleotide reductase inhibitor
- Anticancer
-
|
|
